Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis
Background: For adults undergoing complex, multilevel spinal surgery, tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss. The optimal dosing of intravenous TXA remains unclear. This systematic review and meta-analysis compare various dosing regimens of intravenous TXA used...
Guardado en:
Autores principales: | Roman Rahmani, Amy Singleton, Zachary Fulton, John M. Pederson, Thomas Andreshak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6674fd2cf1174175a5a02b2bc565825b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tranexamic acid and reduction of blood transfusion in lower limb trauma surgery: a randomized controlled study
por: Kaur Gurleen, et al.
Publicado: (2021) -
Dose tranexamic acid reduce blood loss associated with simultaneous bilateral distal tibial tubercle-high tibial osteotomy?
por: Zhimeng Wang, et al.
Publicado: (2021) -
Efficacy and Systemic Absorption of Peri-articular Versus Intra-articular Administration of Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial
por: Piya Pinsornsak, MD, et al.
Publicado: (2021) -
Tranexamic acid achieves less blood loss volume of in primary shoulder arthroplasty: a systematic review and meta-analysis of level I randomized controlled trials
por: DingYuan Fan, MBBS, et al.
Publicado: (2021) -
The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children
por: John M. VanBuren, et al.
Publicado: (2021)